Lisinopril nsaids
Pro Research Analysisby 
Searched over 200M research papers for "lisinopril nsaids"
Interaction Between Lisinopril and NSAIDs: Clinical Implications
Introduction to Lisinopril and NSAIDs
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is widely used to manage hypertension and heart failure. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed for pain and inflammation. However, the concurrent use of these medications can lead to significant interactions affecting their efficacy and safety.
Impact of NSAIDs on Lisinopril's Antihypertensive Effect
Several studies have demonstrated that NSAIDs can attenuate the antihypertensive effects of ACE inhibitors like lisinopril. This interaction is primarily due to NSAIDs' ability to inhibit vasodilatory prostaglandins, leading to vasoconstriction and sodium retention, which counteracts the blood pressure-lowering effects of ACE inhibitors Savenkov2001Beilin2002Pavličević2008+1 MORE.
For instance, a study involving hypertensive patients treated with lisinopril showed that the addition of NSAIDs such as ibuprofen and piroxicam significantly increased systolic blood pressure by 7.7-9.9% . Another study confirmed that indomethacin blunted the antihypertensive efficacy of lisinopril, with an average increase in blood pressure of 5.45/3.22 mmHg .
Mechanisms of Interaction
The interaction between NSAIDs and lisinopril is multifaceted. NSAIDs inhibit cyclooxygenase (COX) enzymes, reducing the synthesis of prostaglandins that promote vasodilation and natriuresis. This inhibition leads to increased vascular resistance and fluid retention, thereby elevating blood pressure Beilin2002Pavličević2011. Additionally, the competitive metabolic interaction between ACE inhibitors and NSAIDs further complicates their concurrent use .
Clinical Implications and Recommendations
Given the potential for NSAIDs to diminish the antihypertensive effects of lisinopril, clinicians should exercise caution when prescribing these medications together. Monitoring blood pressure closely and considering alternative pain management strategies, such as acetaminophen, which has a lesser impact on blood pressure, is advisable Pavličević2008Pavličević2011.
Special Considerations in Renal Patients
In patients with renal disease, the combination of lisinopril and NSAIDs can have both beneficial and adverse effects. While both drug classes can reduce proteinuria, their combined use may lead to a significant decline in glomerular filtration rate (GFR) and increase the risk of hyperkalemia Heeg1990Vogt2008. Therefore, renal function and serum potassium levels should be monitored closely in these patients.
Conclusion
The interaction between lisinopril and NSAIDs is clinically significant, particularly concerning blood pressure control and renal function. Healthcare providers should be aware of these interactions and manage them by monitoring patients closely, considering alternative medications, and adjusting treatment regimens as necessary to ensure optimal therapeutic outcomes.
Sources and full results
Most relevant research papers on this topic
[Antihypertensive effect of enalapril and lisinopril administered in combination with nonsteroid anti-inflammatory agents].
ACE inhibitors should be used differentially in active therapy with NSAIDs due to their metabolic interaction, with lisinopril showing a less negative effect than enalapril.
RP-HPLC Method for the Simultaneous Determination of Lisinopril and NSAIDs in API, Pharmaceutical Formulations and Human Serum
The developed RP-HPLC method effectively determines lisinopril and NSAIDs in pharmaceutical formulations and human serum, providing accurate results for quality control and clinical laboratories.
Interaction between antihypertensives and NSAIDs in primary care: a controlled trial.
Piroxicam and ibuprofen significantly blunt the effects of antihypertensive drugs, while acetaminophen is almost inert, with lisinopril/hydrochlorothiazide being more affected than amlodipine.
Prohypertensive effects of non-steroidal anti-inflammatory drugs are mostly due to vasoconstriction.
NSAIDs' prohypertensive effects are mainly due to vasoconstriction, with minor volume expansion, and no significant changes in body weight, urinary output, serum creatinine, or electrolyte profiles.
Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
Selective COX-2 inhibition reduces proteinuria in renal patients without reducing systemic blood pressure, suggesting a potential non-hypotensive adjunct treatment for proteinuria.
DOI